rs750428090
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001148.6(ANK2):c.2479A>G(p.Ile827Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000958 in 1,460,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001148.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251416Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135886
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1460890Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726840
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
The I827V variant has not been published as a pathogenic or benign variant to our knowledge. This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In addition, the I827V variant has been identified in one individual referred for LQTS testing at GeneDx. Nevertheless, I827V is classified in ClinVar as a variant of uncertain significance in association with LQTS by another clinical laboratory (ClinVar SCV000286238.1; Landrum et al., 2016). The I827V variant is a conservative amino acid substitution, and therefore is not likely to impact secondary protein structure as these residues share similar properties. Additionally, this substitution occurs at a position that is not conserved, and V827 is tolerated in several species. In silico analysis is inconsistent in its predictions; however, at least two models predict the variant is not damaging to the protein structure/function. -
Long QT syndrome Uncertain:1
This variant is present in population databases (rs750428090, gnomAD 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 190525). This variant has not been reported in the literature in individuals affected with ANK2-related conditions. This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 827 of the ANK2 protein (p.Ile827Val). -
Cardiovascular phenotype Uncertain:1
The p.I827V variant (also known as c.2479A>G), located in coding exon 23 of the ANK2 gene, results from an A to G substitution at nucleotide position 2479. The isoleucine at codon 827 is replaced by valine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species, and valine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at